Genomtec S.A. (WSE:GMT)
Poland · Delayed Price · Currency is PLN 3.970
-0.125 (-3.05%)
Dec 15, 2025, 4:48 PM CET
Genomtec Market Cap
Genomtec has a market cap or net worth of 61.69 million as of December 15, 2025. Its market cap has decreased by -34.05% in one year.
Market Cap
61.69M
Enterprise Value
56.42M
Revenue
15.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
3.97
Market Cap Chart
Since March 17, 2021, Genomtec's market cap has decreased from 110.55M to 61.69M, a decrease of -44.20%. That is a compound annual growth rate of -11.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 61.69M | -41.10% |
| Dec 30, 2024 | 104.73M | -21.25% |
| Dec 29, 2023 | 133.00M | 22.23% |
| Dec 30, 2022 | 108.81M | 42.64% |
| Dec 30, 2021 | 76.28M | -31.00% |
| Mar 17, 2021 | 110.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.66B |
| NEUCA | 3.66B |
| Synektik Spólka Akcyjna | 2.30B |
| Voxel | 1.27B |
| Celon Pharma | 1.08B |
| Selvita | 803.97M |
| Ryvu Therapeutics | 608.06M |
| Centrum Medyczne ENEL-MED | 514.70M |